Skip to main content
Fig. 3 | BMC Women's Health

Fig. 3

From: The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis

Fig. 3

Progression-free survival by type of surgery A disease stage B and chemotherapy received C. Log HR for residual disease > 0 vs residual disease = 0. Thick dotted lines represent fixed effects and thin dotted lines represent random effects for the total effect size. CI, confidence interval; HR, hazard ratio; MRAW, raw or untransformed mean

Back to article page